News Headlines Article

Pharmaceutical industry blasts Hillary Clinton’s plan to regulate drug prices
Sacramento Business Journal

The pharmaceutical industry, health insurers and even marketers pushed back against Hillary Clinton’s proposals to limit patients’ costs for prescriptions and end a tax credit for advertising drugs to consumers.

The Democratic presidential candidate called large drug companies “profiteers” in a speech in Iowa on Tuesday as she outlined her proposal to make prescriptions more affordable for consumers. That label may resonate, especially this week, thanks to Turing Pharmaceuticals, which raised the price of a drug, Daraprim, that it had acquired from $13.50 a pill to $750. The anger sparked by this move forced the company to announce it would lower the price.